Renaissance Technologies
CCEL icon

Renaissance Technologies’s Cryo-Cell International CCEL Stock Holding History

Renaissance Technologies’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,184
Closed -$47.3K – 3281
2025
Q3 		$47.3K Buy
+10,184
New +$48.3K ﹤0.01% 3350

Other funds holding CCEL

HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return
SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies's CCEL Position: Q4 2025 in Review

Renaissance Technologies sold out of Cryo-Cell International (CCEL) in Q4 2025, closing a stake of 10,184 shares — an estimated $47.3K sold.

Renaissance Technologies first reported a position in CCEL in Q3 2025 and held it in 1 quarter. The position peaked at $47.3K in Q3 2025. 17 funds tracked by Wall St. Rank hold CCEL as of Q4 2025.

  • Renaissance Technologies reported no remaining Cryo-Cell International position as of Q4 2025 after selling out during the quarter.
  • Renaissance Technologies sold 10,184 Cryo-Cell International shares in Q4 2025, an estimated $47.3K.
  • Renaissance Technologies first reported a position in Cryo-Cell International in Q3 2025 and held it in 1 quarter.
  • Renaissance Technologies's Cryo-Cell International position peaked at $47.3K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held Cryo-Cell International as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.